placebo

GIST adjuvant therapy – some answers and more questions

Number 33

Impact Factor 1 November 2009 0

Imatinib is known to be effective in the first-line treatment of metastatic gastrointestinal stromal tumours. A randomised, placebo-controlled trial has now shown that imatinib is safe and improves recurrence-free survival when used as adjuvant therapy [more]

When is it OK to randomise cancer patients to placebo?

Number 27

Senza categoria 1 November 2008 0

No-one wants to see progress in cancer research more than the patients themselves. But how do we deal with potential conflicts of interest when testing new drugs involves giving placebos to people dying of cancer? [more]